Heart Transplantation in Children and Adults With Congenital Heart Disease: 3 Decades of Evolution

Transplant Proc. 2023 Jul-Aug;55(6):1429-1430. doi: 10.1016/j.transproceed.2023.05.013. Epub 2023 Jun 19.

Abstract

Heart transplantation is the treatment of choice for children and adults with congenital heart disease. We report the heart transplant single-center experience. The number of transplantations has increased over the last 3 decades. The Kaplan-Meier survival curves in the first, second, and third decades at 5 and 10 years were 69% and 59%, 62% and 52%, and 66% and 60%, respectively.

MeSH terms

  • Adult
  • Child
  • Heart Defects, Congenital* / surgery
  • Heart Transplantation* / adverse effects
  • Humans
  • Kaplan-Meier Estimate
  • Retrospective Studies
  • Treatment Outcome